Literature DB >> 4005107

Antipyrine clearance in children from single saliva samples.

S Loft, O Haxholdt, M Døssing.   

Abstract

The saliva clearance of antipyrine was measured in 18 children from four samples taken about 9, 13, 22 and 25 h after ingestion of 20 mg kg-1. Antipyrine clearance determined from each of the samples using a volume of distribution estimated from age (A) and body weight (BW) and height (BH) (V = 1.535 X A + 0.339 X BW + 0.300 X BH - 35.63 (1] correlated closely with clearance determined from the total elimination curve (r greater than 0.94). Random variation and systematic deviation were minimal when the 22 h sample was used for clearance determination (r = 0.98, P less than 0.001, regression curve slope = 1.00, intercept = 0.58 and residual variance = 4.02). The one-sample method for determination of antipyrine saliva clearance is non-invasive, easy to perform and acceptable to children.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005107      PMCID: PMC1463830          DOI: 10.1111/j.1365-2125.1985.tb02698.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  The antipyrine test in clinical pharmacology: conceptions and misconceptions.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

2.  Assessment of antipyrine kinetics by measurement in saliva.

Authors:  H S Fraser; J C Mucklow; S Murray; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

3.  Hepatic drug metabolism and physical fitness.

Authors:  J Boel; L B Andersen; B Rasmussen; S H Hansen; M Døssing
Journal:  Clin Pharmacol Ther       Date:  1984-07       Impact factor: 6.875

4.  Optimal sampling times for minimum variance of clearance determination.

Authors:  M Døssing; A Vølund; H E Poulsen
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

5.  The effect of fever on antipyrine metabolism in children.

Authors:  J S Forsyth; T A Moreland; G W Rylance
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

6.  A one-sample method for antipyrine clearance determination in rats.

Authors:  H Pilsgaard; H E Poulsen
Journal:  Pharmacology       Date:  1984       Impact factor: 2.547

7.  Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.

Authors:  T A Moreland; B K Park; G W Rylance
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

8.  A simple method for determination of antipyrine clearance.

Authors:  M Døssing; H E Poulsen; P B Andreasen; N Tygstrup
Journal:  Clin Pharmacol Ther       Date:  1982-09       Impact factor: 6.875

9.  A method for obtaining saliva samples from infants and young children.

Authors:  C J Bacon; J C Mucklow; A Saunders; M D Rawlins; J K Webb
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

  9 in total
  1 in total

1.  Simplified determination of antipyrine clearance by liquid chromatography of a microsample of saliva or plasma.

Authors:  A el-Yazigi; D A Raines; H Ali; J Sieck; P Ernst; M Dossing
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.